
New U.S. travel rules excludes foreigners vaccinated with Russia's Sputnik V
07 October 2021 21:47
|


Local and foreign media have stepped up reports about rising Covid-19 infections in Russia. The reports indicated high deaths in the country. Some new trends are noticeably appearing. Interestingly, Tourism and Travel agencies have revealed that vaccine uptake has lagged in Russia and worse, due to distrust, so many Russians are lining up for vaccine tourism in Serbia, Bulgaria, Germany and a few other foreign countries.
These Russians aim at
getting foreign vaccines including Pfizer, Moderna and Johnson &
Johnson and AstraZeneca that have been approved by the World Health
Organization. Russia is now pushing for approval to boost confidence in
its domestically developed vaccine, but has encountered administrative
issues thus delaying the decision-making process.
The
World Health Organization is reviewing data about Russia's Sputnik V
coronavirus vaccine before approving it for emergency use. "As with
other candidate vaccines, World Health Organization continues to assess
Sputnik V vaccines from different manufacturing sites and will publish
decisions on their EUL (emergency use listing) status when all the data
are available and the review is concluded," the World Health
Organization said in a statement on October 5.
As
soon as World Health Organization receives all data and inspects
production sites, the UN group can schedule a meeting to validate a
candidate vaccine for an emergency use listing. Without World Health
Organization recognition, people that have taken the Sputnik V vaccine
may be limited in their travel if other countries with entry
restrictions don't recognize the shot.
Here are a few facts about Russian vaccines.
Russia's
Sputnik V was the first officially registered coronavirus vaccine on
August 11, 2020, far faster than the vaccines approved in the United
States and Europe. Currently, Russia is using four vaccines for mass
vaccination for Covid-19. These are Sputnik V and Sputnik Light
developed by the Russian Health Ministry's Gamaleya Center.
EpiVacCorona
developed by the Vector Center of the Federal Service for Surveillance
on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), and
CoviVac developed by the Chumakov Institute of the Russian Academy of
Sciences. Clinical trials of the EpiVacCorona vaccine on teens aged from
15 to 17 might begin in the near future.
China
has 1.3 billion population and marked the two billionth vaccine in
August, the United States has 380 million and vaccinated 60% of its
population. In Europe, vaccination rate is highly at an appreciable
level.
That
compared, Russia with an estimated 146 million people has Europe's
highest death toll from the pandemic, nearly 210,000 people as at
September 30, according to various authentic sources including the
National Coronavirus Task Force. The figures have been hovering daily
around 25,000 new coronavirus cases.
"The
numbers are really very bad, and this is indeed a cause for concern.
The main reason is the insufficient level of vaccination. The virus is
getting more virulent... As a rule, those who have not been vaccinated
are severely ill and unfortunately die," Kremlin Spokesman Dmitry Peskov
told reporters on a conference call.
More
than 42 million Russians have received both components of a coronavirus
vaccine, according to Russian Deputy Prime Minister Tatyana Golikova.
"The
number of citizens who have received the first component of a vaccine
has topped 44 million, and more than 37 million people have completed a
full vaccination course," Golikova said.
She
gave an assurance back in July that once the population have been
immunized with at least the first component of a two-shot vaccine, herd
immunity to Covid-19, or at least an 80% vaccination rate, should be
reached by November 1.
Even
though Russia boasted of creating the world's first coronavirus
vaccines, vaccination is very low. Critics have principally blamed a
botched vaccine rollout and mixed messages the authorities have been
sending about the outbreak. In addition, coronavirus antibody tests are
popular in Russia and some observers suggest this contributes to the low
vaccination numbers.
Western
health experts say the antibody tests are unreliable either for
diagnosing Covid-19 or assessing immunity to it. The antibodies that
these tests look for can only serve as evidence of a past infection.
Scientists say it's still unclear what level of antibodies indicates
that a person has protection from the virus and for how long.
Russia
has registered Sputnik V in many foreign countries. The World Health
Organization is yet to register this vaccine. For its certification, it
must necessarily pass through approved procedures, according reports.
There
have also been several debates after the World Health Organization
paused its review process of the Sputnik V vaccine over concerns about
its manufacturing process, and few other technical reasons. While some
talked about politicizing the vaccine registration, other have faced
facts of observing recognized international rules for certifying medical
products as such vaccines.
During
the first week of October, Russian Health Minister Mikhail Murashko has
reiterated or repeated assertively that a certain package of documents
were needed to continue the process for the approval of the Russian
coronavirus vaccine Sputnik V by the World Health Organization. The
final approval is expected towards the end of 2021.
Still
some the problems with the registration as unfair competition in the
global market. For instance, Russian Minister of Industry and Trade
Denis Manturov said in an interview with the Rossiya-24 television
channel on October 5: "I think it is an element of competition. Until
Pfizer covers a certain part of the market, it is pure economics."
On
the other side, Pyotr Ilyichev, Director for International Organization
at the Russian Foreign Affairs Ministry, told Interfax News Agency, for
instance that World Health Organization has been playing politics
around Russian vaccine especially when it is need in most parts of the
world.
"The
world is facing an acute shortage of vaccines for the novel coronavirus
infection. In certain regions, for instance in African countries, less
than 2% of the population has been vaccinated. The Russian vaccine is in
demand, and the UN stands ready to buy it," he told Interfax.
"However,
certification in the WHO is a complex, multi-step process, which was
developed in the past in line with Western countries' standards. It
requires time and serious efforts from our producers. We hope that this
process will be successfully finalized in the near future," Ilyichev
said.
Chairman
of the State Duma's Foreign Affairs Committee Leonid Slutsky has
described as discriminatory a decision reported by foreign media that
the United States, under its new consular rules, would deny entry for
foreigners immunized with the Russian Covid-19 vaccine Sputnik V.
"Thus,
the U.S. will blatantly embark on a path of 'vaccine discrimination.'
There are absolutely no grounds for such decisions. The efficacy and
safety of the Sputnik V vaccine have been confirmed not only by
specialists, but also by its use in practice," Slutsky said on Telegram.
He
cited an article in The Washington Post saying that from November the
United States may begin denying entry to foreigners vaccinated with
Sputnik V.
It
means that if such additional border measures are adopted, foreigners
seeking entry to the United States will have to be immunized with
vaccines approved for use either by American authorities or the World
Health Organization.
According
to an article published in The Washington Post, for the first time
since the pandemic began, the U.S. intends to loosen entry restrictions
for foreigners vaccinated against Covid-19.
The
new rules, which enter into force in November, will not apply to
Russians vaccinated with Sputnik V and citizens of other countries using
this Russian vaccine.
Under
the new rules, foreigners will enter United States only if they are
immunized with vaccines approved for use by the United States Food and
Drug Administration or the World Health Organization. Russia's Sputnik V
is yet to be approved by the World Health Organization and is not
recognized by the United States.
*Kester Kenn Klomegah writes frequently about Russia, Africa and the
BRICS. As a versatile researcher, he believes that everyone deserves equal
access to quality and trustworthy media reports. Most of his well-resourced
articles are reprinted elsewhere in a number of reputable foreign media.
Leave a comment
- Popular
- Rated
- Commented
04/11/2021 - 11:05:02
28/05/2024 - 15:44:10
02/12/2021 - 11:34:53
01/03/2021 - 09:00:37
Opinions
02/04/2025 - 18:34:53
27/02/2025 - 20:18:23
Politics
17/04/2025 - 01:58:17
13/04/2025 - 10:59:05
Terror Watch
26/04/2025 - 03:43:22
24/04/2025 - 13:30:44
24/04/2025 - 13:07:46
Press Releases
12/04/2025 - 10:30:34
03/04/2025 - 00:16:33
New U.S. travel rules excludes foreigners vaccinated with Russia's Sputnik V
Local and foreign media have stepped up reports about rising Covid-19 infections in Russia. The reports indicated high deaths in the country. Some new trends are noticeably appearing. Interestingly, Tourism and Travel agencies have revealed that vacc